Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...
Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and ...
Health and Me on MSN
Weight loss drug semaglutide cannot slow down Alzheimer’s: Lancet study
Evoke and Evoke+ -- the randomized, double-blind, placebo-controlled phase 3 trials conducted across 566 sites in 40 ...
A new pill for those genetically at risk for Alzheimer’s has shown benefits in clinical trials. FotografiaBasica/Getty Images One gene variant that is particularly associated with Alzheimer’s disease ...
In April, the future was looking bleak for an experimental Alzheimer's drug called valiltramiprosate, or ALZ-801. Researchers had just released topline results of a study of more than 300 people age ...
An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ...
The U.K.’s national health spending watchdog will reevaluate its decision to exclude the use of two Alzheimer’s drugs ...
After a successful appeal, reimbursement authority NICE has said the companies' files will now be sent back to the appraisal ...
Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results